• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清和人白蛋白对羟基磷灰石晶体生长的影响。

The effects of serum and human albumin on calcium hydroxyapatite crystal growth.

作者信息

Garnett J, Dieppe P

机构信息

Department of Medicine, Bristol Royal Infirmary, U.K.

出版信息

Biochem J. 1990 Mar 15;266(3):863-8.

PMID:2158302
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1131218/
Abstract

The effects of potential serum inhibitors upon the growth of calcium hydroxyapatite (HAP) crystals were studied in vivo using a pH-stat system. Whole serum caused a marked decrease in crystal growth in a dose-dependent manner. At a protein concentration of 13 micrograms/ml, whole serum reduced the initial rate of crystal growth from 84 mumol of KOH/h to 48 mumol of KOH/h. Serum components were separated by ultrafiltration (10,000 Da cut-off). The high-molecular-mass fraction containing serum proteins gave an initial rate of crystal growth of 48 mumol of KOH/h compared with 64 mumol of KOH/h given by the low-molecular-mass components. Thus, two-thirds of the inhibitory activity was associated with proteins and other serum macromolecules, whilst the remainder of the activity was associated with the low-molecular-mass components. Albumin-depleted serum showed an initial rate of crystal growth of 59 mumol of KOH/h, whilst albumin purified by affinity chromatography gave an initial rate of crystal growth of 56 mumol of KOH/h at the same protein concentration. Albumin, therefore, not only accounts for half of the protein concentration in serum, but also contributes half of the inhibitory activity of the high-molecular-mass fraction. Heat denaturation of albumin dramatically enhanced the inhibition of HAP seeded growth with the initial rate of crystal growth falling to 27 mumol of KOH/h after treatment compared with 62 mumol of KOH/h before denaturation. Isoelectric focusing indicated that the tertiary and secondary structure, and hence the distribution of surface charge of albumin, are altered by heat denaturation. Gels showed a mixture of species with isoelectric points ranging from 6.0 to 5.0 compared with the native protein value of 4.7. These data suggest that adsorption of serum proteins to the growing HAP crystals is one mechanism of growth inhibition. It is also clear that the most abundant serum protein, albumin, is an important mediator of this process.

摘要

利用pH计系统在体内研究了潜在血清抑制剂对羟基磷灰石(HAP)晶体生长的影响。全血清以剂量依赖的方式显著降低晶体生长。在蛋白质浓度为13微克/毫升时,全血清将晶体生长的初始速率从84微摩尔氢氧化钾/小时降至48微摩尔氢氧化钾/小时。通过超滤(截留分子量10,000道尔顿)分离血清成分。含有血清蛋白的高分子量部分晶体生长的初始速率为48微摩尔氢氧化钾/小时,而低分子量成分的初始速率为64微摩尔氢氧化钾/小时。因此,三分之二的抑制活性与蛋白质和其他血清大分子相关,而其余活性与低分子量成分相关。去除白蛋白的血清晶体生长的初始速率为59微摩尔氢氧化钾/小时,而通过亲和色谱纯化的白蛋白在相同蛋白质浓度下晶体生长的初始速率为56微摩尔氢氧化钾/小时。因此,白蛋白不仅占血清蛋白质浓度的一半,而且还贡献了高分子量部分抑制活性的一半。白蛋白的热变性显著增强了对HAP接种生长的抑制作用,处理后晶体生长的初始速率从变性前的62微摩尔氢氧化钾/小时降至27微摩尔氢氧化钾/小时。等电聚焦表明,热变性改变了白蛋白的三级和二级结构,从而改变了其表面电荷分布。凝胶显示出等电点范围从6.0到5.0的多种物种混合物,而天然蛋白质的等电点为4.7。这些数据表明血清蛋白吸附到生长的HAP晶体上是生长抑制的一种机制。同样明显的是,血清中最丰富的蛋白质白蛋白是这一过程的重要介质。

相似文献

1
The effects of serum and human albumin on calcium hydroxyapatite crystal growth.血清和人白蛋白对羟基磷灰石晶体生长的影响。
Biochem J. 1990 Mar 15;266(3):863-8.
2
The effect of synovial fluid and serum on the growth of calcium hydroxyapatite crystals.
J Rheumatol. 1990 Apr;17(4):515-20.
3
Inhibition of hydroxyapatite crystal growth by bone proteoglycans and proteoglycan components.骨蛋白聚糖和蛋白聚糖成分对羟基磷灰石晶体生长的抑制作用。
Biochem Biophys Res Commun. 2002 Apr 5;292(3):727-33. doi: 10.1006/bbrc.2002.6699.
4
Effects of heat treatment of calcium hydroxyapatite particles on the protein adsorption behavior.羟基磷灰石颗粒热处理对蛋白质吸附行为的影响。
J Phys Chem B. 2009 Aug 6;113(31):11016-22. doi: 10.1021/jp904481z.
5
Microcalorimetric study of protein adsorption onto calcium hydroxyapatites.蛋白质吸附到羟基磷灰石上的微量热研究。
Langmuir. 2007 Feb 13;23(4):2064-70. doi: 10.1021/la062562n.
6
Adsorption and interactions of dentine phosphoprotein with hydroxyapatite and collagen.牙本质磷蛋白与羟基磷灰石及胶原蛋白的吸附和相互作用。
Eur J Oral Sci. 2006 Jun;114(3):223-31. doi: 10.1111/j.1600-0722.2006.00347.x.
7
Synthesis of positively charged calcium hydroxyapatite nano-crystals and their adsorption behavior of proteins.带正电荷的羟基磷灰石纳米晶体的合成及其对蛋白质的吸附行为。
Colloids Surf B Biointerfaces. 2009 Oct 1;73(1):140-5. doi: 10.1016/j.colsurfb.2009.05.011. Epub 2009 May 19.
8
Protein adsorption characteristics of calcium hydroxyapatites modified with pyrophosphoric acids.焦磷酸修饰的羟基磷灰石的蛋白质吸附特性
Colloids Surf B Biointerfaces. 2007 Aug 1;58(2):98-104. doi: 10.1016/j.colsurfb.2007.02.014. Epub 2007 Feb 25.
9
Effect of fluoride on crystal growth of calcium apatites in the presence of a salivary inhibitor.在存在唾液抑制剂的情况下氟化物对钙磷灰石晶体生长的影响。
Calcif Tissue Int. 1982;34 Suppl 2:S33-40.
10
Interaction of amelogenin with hydroxyapatite crystals: an adherence effect through amelogenin molecular self-association.釉原蛋白与羟基磷灰石晶体的相互作用:通过釉原蛋白分子自组装产生的黏附效应。
Biopolymers. 1998 Oct 5;46(4):225-38. doi: 10.1002/(SICI)1097-0282(19981005)46:4<225::AID-BIP4>3.0.CO;2-R.

引用本文的文献

1
BMP-4 and fetuin A in systemic sclerosis patients with or without calcinosis.伴有或不伴有钙质沉着症的系统性硬化症患者体内的骨形态发生蛋白-4(BMP-4)和胎球蛋白A
Front Immunol. 2024 Dec 3;15:1502324. doi: 10.3389/fimmu.2024.1502324. eCollection 2024.
2
New insights into the prevention of ureteral stents encrustation.输尿管支架结壳预防的新见解。
Open Med (Wars). 2023 Dec 6;18(1):20230854. doi: 10.1515/med-2023-0854. eCollection 2023.
3
Formation of Hydroxyapatite-Based Hybrid Materials in the Presence of Platelet-Poor Plasma Additive.在缺乏血小板血浆添加剂存在的情况下羟基磷灰石基杂化材料的形成
Biomimetics (Basel). 2023 Jul 9;8(3):297. doi: 10.3390/biomimetics8030297.
4
Caries Management-The Role of Surface Interactions in De- and Remineralization-Processes.龋病管理——表面相互作用在脱矿和再矿化过程中的作用
J Clin Med. 2022 Nov 28;11(23):7044. doi: 10.3390/jcm11237044.
5
A Breakthrough in Understanding the Pathogenesis of Molar Hypomineralisation: The Mineralisation-Poisoning Model.理解磨牙矿化不全发病机制的一项突破:矿化中毒模型。
Front Physiol. 2021 Dec 21;12:802833. doi: 10.3389/fphys.2021.802833. eCollection 2021.
6
Bone Matrix Non-Collagenous Proteins in Tissue Engineering: Creating New Bone by Mimicking the Extracellular Matrix.组织工程中的骨基质非胶原蛋白:通过模拟细胞外基质创造新骨
Polymers (Basel). 2021 Mar 30;13(7):1095. doi: 10.3390/polym13071095.
7
Associations of Serum Calciprotein Particle Size and Transformation Time With Arterial Calcification, Arterial Stiffness, and Mortality in Incident Hemodialysis Patients.血清钙磷复合物颗粒大小和转化时间与新发生血液透析患者动脉钙化、动脉僵硬度和死亡率的相关性。
Am J Kidney Dis. 2021 Mar;77(3):346-354. doi: 10.1053/j.ajkd.2020.05.031. Epub 2020 Aug 13.
8
Tooth Enamel and its Dynamic Protein Matrix.牙釉质及其动态蛋白基质。
Int J Mol Sci. 2020 Jun 23;21(12):4458. doi: 10.3390/ijms21124458.
9
Patients with advanced chronic kidney disease and vascular calcification have a large hydrodynamic radius of secondary calciprotein particles.患有晚期慢性肾脏病和血管钙化的患者具有较大的次级钙磷蛋白颗粒的水动力半径。
Nephrol Dial Transplant. 2019 Jun 1;34(6):992-1000. doi: 10.1093/ndt/gfy117.
10
The role of fetuin-A in mineral trafficking and deposition.胎球蛋白-A在矿物质运输与沉积中的作用。
Bonekey Rep. 2015 May 6;4:672. doi: 10.1038/bonekey.2015.39. eCollection 2015.

本文引用的文献

1
Calcium-acidic phospholipid-phosphate complexes in diseased and normal human bone.
Metab Bone Dis Relat Res. 1982;4(2):151-6. doi: 10.1016/0221-8747(82)90029-7.
2
Molecular aspects of ligand binding to serum albumin.配体与血清白蛋白结合的分子层面
Pharmacol Rev. 1981 Mar;33(1):17-53.
3
Measurement of inhibitors of calcium phosphate precipitation in plasma ultrafiltrate.血浆超滤液中磷酸钙沉淀抑制剂的测定。
Am J Physiol. 1984 May;246(5 Pt 2):F648-55. doi: 10.1152/ajprenal.1984.246.5.F648.
4
Purification and characterization of the principal inhibitor of calcium oxalate monohydrate crystal growth in human urine.人尿中一水草酸钙晶体生长主要抑制剂的纯化与特性研究
J Biol Chem. 1983 Oct 25;258(20):12594-600.
5
Phospholipids associated with human parotid gland sialoliths.
Arch Oral Biol. 1983;28(7):655-7. doi: 10.1016/0003-9969(83)90015-8.
6
The molecular characteristics of a human pancreatic acidic phosphoprotein that inhibits calcium carbonate crystal growth.一种抑制碳酸钙晶体生长的人胰腺酸性磷蛋白的分子特征。
Biochem J. 1984 Sep 15;222(3):669-77. doi: 10.1042/bj2220669.
7
Adsorption of molecules of biological interest onto hydroxyapatite.具有生物学意义的分子在羟基磷灰石上的吸附。
Calcif Tissue Int. 1984 Jan;36(1):48-59. doi: 10.1007/BF02405293.
8
Calcification inhibitors in rat and human serum and plasma.大鼠和人血清及血浆中的钙化抑制剂
Biochim Biophys Acta. 1984 Jun 15;799(2):115-21. doi: 10.1016/0304-4165(84)90284-8.
9
Calcific diseases. A concept.钙化性疾病。一个概念。
Arch Pathol Lab Med. 1983 Jul;107(7):341-8.
10
Structural factors influencing the ability of compounds to inhibit hydroxyapatite formation.影响化合物抑制羟基磷灰石形成能力的结构因素。
Calcif Tissue Int. 1982 Mar;34(2):169-77. doi: 10.1007/BF02411229.